Results 11 to 20 of about 35,093 (194)

Lasers in primary open angle glaucoma

open access: yesIndian Journal of Ophthalmology, 2011
Lasers have been used in the treatment of primary open angle glaucoma (POAG) over the years, with the hope that they would eventually replace medical and surgical therapy.
Sihota Ramanjit
doaj   +3 more sources

PRIMARY OPEN-ANGLE GLAUCOMA [PDF]

open access: yesAJN, American Journal of Nursing, 2009
Primary open-angle glaucoma (POAG), by far the most common form of glaucoma, currently afflicts more than 2 million Americans, more than half of whom probably don't know they have it. Asymptomatic in the early stages, it gradually and progressively reduces the visual field and leads to blindness if untreated.
Nancy C, Sharts-Hopko   +1 more
  +8 more sources

Etiopathogenesis of primary open-angle glaucoma [PDF]

open access: yesVestnik oftal'mologii, 2020
The article reviews literature covering the etiopathogenesis and risk factors for the development of primary open-angle glaucoma (POAG). Currently, this problem is one of the most complex and controversial in ophthalmology. The review considers the main theories: vascular, mechanical (retentional, hydromechanical), dystrophic (theory of primary ...
N V, Eliseeva, M I, Churnosov
openaire   +2 more sources

Biomarkers of primary open-angle glaucoma [PDF]

open access: yesExpert Review of Ophthalmology, 2010
Primary open-angle glaucoma (POAG) is a primary neuronal disease of the optic nerve without a definable cause, and is often associated with increased intraocular pressure. Worldwide, POAG is the second leading cause of blindness; there are 45 million people today with POAG and bilateral blindness is present in 4.5 million of these.
Paul A, Knepper   +2 more
openaire   +2 more sources

Neuroinflammation in Primary Open-Angle Glaucoma [PDF]

open access: yesJournal of Clinical Medicine, 2020
Primary open-angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide. Increasing evidence suggests oxidative damage and immune response defects are key factors contributing to glaucoma onset. Indeed, both the failure of the trabecular meshwork tissue in the conventional outflow pathway and the neuroinflammation process ...
Stefania Vernazza   +4 more
openaire   +2 more sources

The genetics of primary open angle glaucoma [PDF]

open access: yesBritish Journal of Ophthalmology, 1997
The advent of the discipline of molecular genetics over the past decade has led to a dramatic growth in our understanding of the genetics of a myriad of diseases. Ophthalmology has benefited greatly from this new technology, with significant advances in our knowledge about conditions as varied as aniridia and retinitis pigmentosa.1 2 Our understanding ...
A, Booth   +4 more
openaire   +2 more sources

Biomarkers in primary open angle glaucoma

open access: yesClinical Chemistry and Laboratory Medicine (CCLM), 2012
Abstract Glaucoma, a leading cause of blindness worldwide, is currently defined as a disturbance of the structural or functional integrity of the optic nerve that causes characteristic atrophic changes in the optic nerve, which may lead to specific visual field defects over time.
Kokotas, H.   +6 more
openaire   +3 more sources

Comparison of central corneal thickness of primary open angle glaucoma patients with normal controls in South India

open access: yesOman Journal of Ophthalmology, 2013
Background: Studies mainly in the western population have compared central corneal thickness in primary open angle glaucoma and normal individuals have found variable results.
Maya Natarajan   +2 more
doaj   +1 more source

[Primary open-angle glaucoma]. [PDF]

open access: yesLa Revue de medecine interne, 2020
Primary open-angle glaucoma is a progressive chronic optic neuropathy, typically bilateral, that occurs after the age of 40 years. It is the second leading cause of irreversible blindness in the world. Primary open-angle glaucoma corresponds to a progressive loss of retinal ganglion cell characterized by an excavation of the optic disc associated with ...
S, Bertaud   +3 more
openaire   +3 more sources

MicroRNAs as biomarkers in glaucoma and potential therapeutic targets

open access: yesNeural Regeneration Research, 2022
Glaucoma is a neurodegenerative disease in which optic nerve damage and visual field defects occur. It is a leading cause of irreversible blindness. Its pathogenesis is largely unknown although several risk factors have been identified, with an increase ...
Bridget Martinez, Philip V Peplow
doaj   +1 more source

Home - About - Disclaimer - Privacy